Orforglipron: The Oral GLP-1 in Development: What the Trials Show and What Is Not Yet Known
Orforglipron is an investigational once-daily oral GLP-1 receptor agonist, a small-molecule pill rather than an injected peptide. In published phase 3 trials, adults with…







